Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Altimmune, Inc. (ALT)

3.4200 +0.1900 (+5.88%)
At close: September 4 at 4:00:01 PM EDT
3.4400 +0.0200 (+0.58%)
After hours: September 4 at 7:48:36 PM EDT
Trade ALT on Coinbase
Chart Range Bar
Loading chart for ALT

What's happening with ALT?

59m ago
Powered by Yahoo Scout

Altimmune is advancing its pipeline in liver disease treatments, particularly with pemvidutidefor metabolic dysfunction-associated steatohepatitis (MASH) and alcohol use disorder (AUD). The company reported a net loss of $22.8 millionin Q2 2026, but holds $519 millionin cash to fund ongoing trials and strategic developments.

Powered by Yahoo Scout
  • Previous Close 3.2300
  • Open 3.2800
  • Bid 2.2400 x 200
  • Ask 3.9200 x 200
  • Day's Range 3.2500 - 3.4300
  • 52 Week Range 2.5600 - 6.4400
  • Volume 4,849,066
  • Avg. Volume 4,464,370
  • Market Cap (intraday) 665.251M
  • Beta (5Y Monthly) 0.18
  • PE Ratio (TTM) --
  • EPS (TTM) -0.8100
  • Earnings Date (est.) Nov 5, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jan 20, 2017
  • 1y Target Est 17.22

Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

altimmune.com

57

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ALT
5.26%
S&P 500 (^GSPC)
12.75%

1-Year Return

ALT
3.93%
S&P 500 (^GSPC)
18.71%

3-Year Return

ALT
29.06%
S&P 500 (^GSPC)
70.93%

5-Year Return

ALT
79.18%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue --
Earnings -22.56M
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

-25M
-20M
-15M
-10M
-5M
0
-300000.0%
-200000.0%
-100000.0%
0.0%

Analyst Insights

View More

Top Analyst

B. Riley Securities
52/100
Latest Rating
Buy

Analyst Price Targets

11.00
17.22 Average
3.4200 Current
28.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 6/22/2026
Analyst Leerink Partners
Rating Action Initiated
Rating Outperform
Price Action Announces
Price Target 10

Statistics

View More

Valuation Measures

Annual
As of 9/2/2026
  • Market Cap

    638.02M

  • Enterprise Value

    347.76M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    13.37k

  • Price/Book (mrq)

    1.35

  • Enterprise Value/Revenue

    11.22k

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -17.20%

  • Return on Equity (ttm)

    -28.87%

  • Revenue (ttm)

    31k

  • Net Income Avi to Common (ttm)

    -91.76M

  • Diluted EPS (ttm)

    -0.8100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    326.28M

  • Total Debt/Equity (mrq)

    7.60%

  • Levered Free Cash Flow (ttm)

    -48.79M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

3.4200 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Insider Picks for 04/08/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 04/07/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 04/03/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 04/02/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: